Beta Bionics, Inc. Depreciation
Beta Bionics, Inc. (BBNX) reported Depreciation of $1.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-29
- Beta Bionics, Inc. depreciation for the quarter ending 2026-06-30 was $709.00K, a 104.32% increase year-over-year.
- Beta Bionics, Inc. depreciation for the quarter ending 2026-03-31 was $585.00K, a 93.07% increase year-over-year.
- Beta Bionics, Inc. depreciation for the quarter ending 2025-12-31 was $538.00K, a 131.90% increase year-over-year.
- Beta Bionics, Inc. depreciation for the quarter ending 2025-09-30 was $385.00K, a 15.62% increase year-over-year.
- Beta Bionics, Inc. depreciation for fiscal 2025 was $1.57M, a 36.66% increase from fiscal 2024.
- Beta Bionics, Inc. depreciation for fiscal 2024 was $1.15M, a 6.12% decline from fiscal 2023.
- Beta Bionics, Inc. depreciation for fiscal 2023 was $1.23M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $709.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.29M 10-Q · filed 2026-07-29 | $1.83M derived: sum of 3 quarters · filed 2026-07-29 | $2.22M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $585.00K 10-Q · filed 2026-04-21 | $1.12M derived: sum of 2 quarters · filed 2026-04-21 | $1.51M derived: sum of 3 quarters · filed 2026-04-21 | $1.85M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $923.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.27M derived: sum of 3 quarters · filed 2026-07-29 | $1.57M 10-K · filed 2026-02-24 |
| 2025-09-30 | $385.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $732.00K derived: sum of 2 quarters · filed 2026-07-29 | $1.03M 10-Q · filed 2025-10-28 | $1.27M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $347.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $650.00K 10-Q · filed 2026-07-29 | $882.00K derived: sum of 3 quarters · filed 2026-07-29 | $1.22M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $303.00K 10-Q · filed 2026-04-21 | $535.00K derived: sum of 2 quarters · filed 2026-04-21 | $868.00K derived: sum of 3 quarters · filed 2026-04-21 | $1.17M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $565.00K derived: sum of 2 quarters · filed 2026-02-24 | $864.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.15M 10-K · filed 2026-02-24 |
| 2024-09-30 | $333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $632.00K derived: sum of 2 quarters · filed 2025-10-28 | $919.00K 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $299.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $586.00K 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $287.00K 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $1.23M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |